CAR peptide can be co-administered with other medications to increase localized therapeutic bioavailability, boost therapeutic efficacy in a targeted manner, and minimize systemic side effects. As CAR peptide homes to, and penetrates areas of disease activity, co-administered medicines will preferentially accumulate in these diseased areas resulting in higher localized therapeutic concentrations. By causing co-administered therapeutics to achieve higher concentrations in diseased tissue, CAR peptide enables targeted therapies that are localized to the areas of disease. By concentrating co-administered therapeutics in the areas of disease, CAR peptide can also reduce off-target systemic side effects.
- Learn more about how the CAR peptide works
- Applications for the CAR peptide
- CAR Peptide Scientific Articles
- For inquiries about CAR peptide and other VBS pharmaceutical products,
please contact us at firstname.lastname@example.org
DISCLAIMER: The material provided on this site is strictly for informational purposes. Do not use this site as a substitute for medical care or medical advice. Please consult with your physician or other medical care provider regarding any medical questions you may have.